Market Tracker

10/01 5:56am ET

Myriad Genetics Inc (NASDAQ:MYGN)

38.57
Data as of Sep 30
 -0.30 / -0.77%
Today’s Change
20.02
Today|||52-Week Range
42.50
+83.84%
Year-to-Date

Today’s Trading

Previous close38.87
Today’s open38.83
Day’s range-- - --
Volume497,735
Average volume (3 months)725,545
Market cap$2.8B
Dividend yield--
Data as of 09/30/2014

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-20.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+26.92%
P/E ratio17.1
Price/Sales3.79
Price/Book3.97

Competitors

 Today’s
change
Today’s
% change
NPSPNPS Pharmaceuticals ...-1.03-3.81%
--Cosmo Pharmaceutical...-11.95-6.38%
ACADACADIA Pharmaceutica...-0.91-3.54%
WXWuXi Pharmatech (Cay...+0.74+2.16%
Data as of 09/30/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts